A global biodiversity fund seeks payment from sectors benefitting from digital sequencing information – potentially covering agriculture, biotech, cosmetics, pharma and AI. Bart Van Vooren at Covington & Burling tells Forward Law Review why the UN-backed plan, as it stands, will fail.
